Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $118.31M | $110.93M | $49.12M | $44.06M |
| Net Income | -$2.61M | $7.35M | -$35.78M | -$26.68M |
| EPS Diluted | -$0.02 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| $0.06 |
| -$0.30 |
| -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.